Tag: Gene therapy

Meet the World’s most expensive drug: Zolgensma

Articles

The U.S. FDA recently approved the much talked about Novartis’s drug Zolgensma for treating a life-threatening condition Spinal Muscular...

Read More

Can commoners afford to spend million dollars on GENE Therapy?

Articles, Business Consultant, Chimeric Antigen Receptor (CAR) T-cell Therapy, DelveInsight's Drug Report, Pharma Consultant

Each country has a unique system, politics, and economy. Different policies are designed to suit people of different countries. Same goes...

Read More

The Business Cocktail

Anti-coagulants, API Business Opportunity, Articles, Atrial Fibrillation, Business Consultant, Pharma Consultant

Biohaven buys PRV from GW Pharmaceuticals for USD 105 million GW Pharmaceuticals has announced its decision to sell its rare pediatric...

Read More

Is Gene Therapy the Next Cancer Treatment Revolution? 

Articles, Business Consultant, Chimeric Antigen Receptor (CAR) T-cell Therapy, Gene Therapy Products, Pharma Consultant • 4 Comments

Gene Therapy is now touted as a new revolution for cancer treatment. If the list of new cancer treatment methodologies is traversed, then...

Read More

Notizia

Notizia

EMA to relocate to Amsterdam by March 2019 Results of the Monday’s vote for the European Medicines Agency relocation led to the...

Read More

Bubble Boy Syndrome (ADA-SCID) – A Rare Immunodeficiency Disorder

Articles, Business Consultant, Pharma Consultant • One Comment

Severe Combined Immunodeficiency (SCID) is an inherited primary immunodeficiency disease (PIDD) that typically presents in infancy. It is...

Read More
Close